FEVAR: is still the preferred therapeutic option for juxtarenal aortic aneurysms?

J Cardiovasc Surg (Torino). 2020 Feb;61(1):1. doi: 10.23736/S0021-9509.19.11198-6. Epub 2019 Nov 18.

Authors

Konstantinos P Donas¹, Stefano Fazzini², Martin Austermann², Mauro Gargiulo³, Enrico Gallitto³, Giovanni Torsello²

Affiliations

¹ Department of Vascular Surgery, St. Franziskus Hospital Münster, Münster, Germany - [email protected].
² Department of Vascular Surgery, St. Franziskus Hospital Münster, Münster, Germany.
³ Unit of Vascular Surgery, Department of Experimental, Diagnostic and Speciality Medicine, Sant'Orsola-Malpighi Polyclinic, University of Bologna, Bologna, Italy.

PMID: 31755682
DOI: 10.23736/S0021-9509.19.11198-6

No abstract available

Publication types

Introductory Journal Article

MeSH terms

Aortic Aneurysm, Abdominal / surgery*
Blood Vessel Prosthesis Implantation / adverse effects
Blood Vessel Prosthesis Implantation / methods*
Endovascular Procedures / adverse effects
Endovascular Procedures / methods*
Humans